8-(6-Methoxy-3-pyridinyl)-3-methyl-1-[4-(1-piperazinyl)-3-(trifluoromethyl)phenyl]-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one (2Z)-2-butenedioate (1:1)(CAS: 1245537-68-1)

The compound is a crystalline solid with a molecular weight of approximately 734.63 g/mol. It has a low water solubility and exhibits moderate reactivity under normal conditions. Notable properties include its stability to light and air, but it is sensitive to moisture and should be stored accordingly.

This compound is synthesized through a multi-step process involving the condensation of 2-(4-amino-3-(trifluoromethyl)phenyl)-1-piperazineethanol with 6-methoxy-3-pyridinecarbaldehyde, followed by ring closure and substitution reactions. The synthesis typically uses mild conditions and mild bases, yielding a product with good purity.

This compound is primarily used in the pharmaceutical industry for its potential as a therapeutic agent. It may also find applications in the development of new materials, specifically in areas such as sensors and semiconductors, although its use in these industries is less common.

When handling this compound, it is crucial to use appropriate personal protective equipment (PPE) such as gloves, lab coat, and safety goggles. It should be stored in a cool, dry place away from moisture and should be handled under a fume hood due to its sensitivity to moisture. Proper spill cleanup procedures should be followed, and the Safety Data Sheet (SDS) should be consulted for detailed instructions.